
Wysrlin T 4000mg/500mg Injection
Marketer
Wysr Healthcare
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Wysrlin T 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection is a dual-antibiotic formulation indicated for diverse bacterial infections. Its mechanism involves microbial eradication. Administration should be solely by a qualified healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on your condition's severity. Adherence to prescribed usage is crucial. Commonly reported adverse effects include gastrointestinal upset (nausea, vomiting, diarrhea) and skin reactions (rash). Injection site reactions such as pain, swelling, or erythema may also occur. Persistent or worsening side effects necessitate immediate medical attention. Prior to treatment, disclose any antibiotic allergies, renal or hepatic impairment to your doctor, who may adjust the regimen accordingly. Under medical guidance, this medication is generally deemed safe for pregnant and breastfeeding individuals.
Uses of Wysrlin T 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Wysrlin T 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Wysrlin T 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Wysrlin T 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Wysrlin T 4000mg/500mg Injection works:
Wysrlin T, a 4000mg/500mg injectable formulation, unites piperacillin, a broad-spectrum antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby bolstering piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Wysrlin T 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Wysrlin T (4000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials using animals have revealed minimal or absent negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Wysrlin T (4000mg/500mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal to negligible transfer of the drug into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Wysrlin T 4000mg/500mg Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
The injectable formulation of Wysrlin T (4000mg/500mg) requires careful administration in individuals with impaired renal function. Dosage modification of Wysrlin T (4000mg/500mg) injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Wysrlin T 4000mg/500mg Injection in patients with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Wysrlin T 4000mg/500mg Injection :
Omitting a scheduled dose of Wysrlin T 4000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Wysrlin T 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
